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Abstract
Introduction: Respiratory Syncytial Virus is a common neonatal pathogen. Here we present a case
of a premature, low birth weight infant who contracted respiratory syncytial virus and developed a
severe pulmonary hemorrhage.
Case presentation: A 12-day-old Asian male, former 30-week premature infant with a birth weight
of 1025 grams presented with nasal secretions, episodes of desaturations and increased work of
breathing. The infant developed a pulmonary hemorrhage. Secretions during tracheal lavage were
positive for respiratory syncytial virus on rapid fluorescence assay. After supportive care, the patient
improved. Isolation, cohorting techniques and reinforcement of strict hand-washing guidelines
prevented an outbreak to other infants.
Conclusion: This original case report presents an uncommon presentation of respiratory syncytial
virus infection, a common pediatric pathogen. Neonatologists should consider evaluating patients
with pulmonary hemorrhage for respiratory syncytial virus if preceding symptoms are consistent with
that infectious illness.
Introduction
Respiratory Syncytial Virus (RSV) is a potentially lethal
pathogen in the pediatric population [1]. Particularly
affected are premature infants less than six months old.
RSV is a major cause of apnea, respiratory distress,
respiratory failure and obstructive lung disease [2,3]. We
are the first to describe RSV and an association for acute
pulmonary hemorrhage in a 1000 gram premature infant.
We further review mechanisms and evidence for contain-
ing the spread of this pathogen upon detection in the
neonatal intensive care unit (NICU).
Case presentation
Our patient, a 12-day-old Asian male infant, weighed
1025 grams and was the second twin born of in-vitro
fertilized donor eggs to a 47-year-old nulliparous woman
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at 301/7 weeks gestation. The pregnancy was complicated
by hypertension requiring 10 days of hospitalization prior
to delivery for administration of labetolol. Her condition
was associated with normal liver function tests and a
platelet count of 150,000/ mcl. Prior to delivery, the
mother received dexamethasone and ampicillin therapy
because of the unknown status of her group B streptococcus
cervical cultures. Premature spontaneous vaginal delivery
(ascribed to hypertension and mild toxemia) was compli-
cated with breech presentation and poor respiratory effort
requiring 30 seconds of positive-pressure ventilation.
Apgar scores were 5 at one minute and 7 at five minutes.
The infant was intubated for worsening respiratory distress
at 20 minutes of life. Initial arterial blood gas demon-
strated a pH of 7.35, carbon dioxide of 44 mmHg, PaO2
of 66 mmHg with a bicarbonate level of 23 mg/dl and a
base deficit of -1.6. Beractant was delivered via endotracheal
tube at 1.5 hours of life. Echocardiography revealed a 2 mm
patent ductus arteriosis on the first day of life treated with
72 hours of indomethicin. Repeat echocardiography
demonstrated closure of the ductus. Feeds were begun, via
naso-gastric tube, on the third day of life. Antibiotic therapy
with ampicillin and gentamicin were continued for a total
of seven days for presumed bacteremia. Complete blood
count at birth was not significantly abnormal revealing a
WBC count of 7,500 /mcl, a hematocrit of 53%, however
platelets were low at 132,000 andwere attributed to the low
maternal platelet count. Initial immature to total neutrophil
ratio on admission was 0.2. Initial cranial ultrasound was
normal for gestational age.
The patient weaned from conventional mechanical venti-
lation and was extubated to nasal continuous positive
airway pressure of 5 cm H2O on the second day of life. He
required only nasal cannula supplementation by his
seventh day of life. On the twelfth day of life, at a weight
of 1045 grams, the infant presented with increasing nasal
secretions and oxygen desaturation episodes. Within
45 minutes the patient’s work of breathing increased and
his respiratory rate rose to 100 breaths/minute requiring
intubation. Large amounts of fresh blood were noted
upon laryngoscopy prior to intubation. Extensive bleeding
was noted after endotracheal tube placement with
worsening respiratory function requiring increased venti-
latory settings in 100% Fio2 to maintain pulse oximetry
saturations of 87%. Arterial blood gas and complete blood
count sampling at this time were significant for a pH of
6.99, carbon dioxide of 74 mmHg, paO2 of 48 mmHg
with a base deficit of -15. The infant’s hematocrit
decreased from 30.1% the previous day to 19% with a
platelet count of 252,000. Mean arterial pressure decreased
from a baseline of 33 mmHg to 27 mmHg with associ-
ated tachycardia to 220 beats per minute. Partial
thromboplastin time and prothrombin time at this time
were normal for gestational age. Chest X-Ray (Figure 1)
was consistent with acute pulmonary hemorrhage.
After placement on high frequency oscillatory ventilation
(HFOV) as well as three rapid infusions of packed red
blood cells, the infant stabilized. Treatment with vanco-
mycin, cefotaxime and acyclovir were initiated. Blood
Figure 1. Chest X-ray: Left panel: The patient’s chest X-ray the evening before demonstrating a coarse lung fields without diffuse
or focal infiltrates consistent with respiratory distress syndrome. Right panel: Immediately after acute respiratory compensation,
diffuse areas of infiltrates encompassing the entire lung fields consistent with diffuse pulmonary hemorrhage.
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culture and surface cultures for herpes simplex virus were
negative. The possibility of RSV was entertained upon
discussion with the nurse caring for the infant. She noted
the patient’s father engaged in kangaroo care with the
infant and his twin while exhibiting clear rhinorrhea and
sneezing. Rapid RSV and influenza studies were sent from
both nasal secretions and tracheal aspirates. Rapid RSV
was positive in both specimens and RSV was also
demonstrated from the father’s secretions via rapid assay.
Antibiotics were discontinued after 48-hours of blood
cultures demonstrating no growth. Infectious disease
consultation did not recommend use of ribavirin [4,5].
Nasal viral cultures and viral electron microscopy were
positive for RSV but negative for the presence of other
viruses.
The patient remained on HFOV for three additional days
prior to weaning to conventional ventilation for 15
additional days. Head ultrasonography on day of life 19
demonstrated increased echogenicity in the left periven-
tricular white matter consistent with cerebral ischemia as
compared to a normal initial study obtained at seven days
of age. The patient was discharged on hospital day 147.
Discussion
RSV can be amajor contributor to morbidity andmortality
once in the NICU [6]. Once infection of host cells occurs,
epithelial cell necrosis leads to the production of mucus
plugs combined with cellular debris and subsequent
inflammation, creating a one-way valve mechanism for
air entry and localized atelectasis, leading to hyperinfla-
tion [3]. With decreased immune function, narrow
alveolar diameters, decreased lung volume and under-
developed lung anatomy; premature infants are uniquely
susceptible hosts to this pathogen [6].
Though the major clinical manifestations of RSV include
increased secretions associated with obstructive-type lung
disease, apnea, wheezing and respiratory distress, we
report the first case of pulmonary hemorrhage associated
with RSV infection in an otherwise stable low birth weight
infant. Risk factors for pulmonary hemorrhage in neonates
include prematurity, mechanical ventilation, bleeding
diathesis, patent ductus arteriosis, exogenous surfactant
administration, and barotrauma. Given the multi-factorial
nature of pulmonary hemorrhage and the presence of risk
factors in this infant, direct causality of RSV cannot be
determined.
However, the patient’s negative blood cultures, failure to
improve on antibiotics, negative viral cultures for other
viruses such as adenovirus, normal coagulation profile
and positive RSV assay argue for this agent as a probable
factor for pulmonary hemorrhage, especially in the
context of a known sick contact. Further studies are
required to further clarify the relationship between these
two conditions.
Numerous outbreaks of RSV in the NICU have been
described [7-9]. Given its high degree of infectivity and
ability to survive on inanimate surfaces, the NICU allows
for efficient spread of the virus to other neonates,
especially if strict hand washing policies are not enforced.
Thus once an index case is discovered, it is critical to
prevent spread of the pathogen and secondary cases.
Currently, American Academy of Pediatric (AAP) guide-
lines for control of nosocomial RSV infection is strict
adherence to infection control practices, including:
1) Strict handwashing policies before and after each
patient contact for 15 seconds.
2) Laboratory screening of patients for RSV infection.
3) Cohorting infected patients and staff.
4) Exclusion of visitors and staff with respiratory tract
infections.
5) Use of gowns, gloves goggles and masks.
These guidelines were directed at the older age high-risk
pediatric hospital population, not the closed environment
of the NICU. Kilani described a stricter infection control
policy during eight cases of RSV in the neonatal unit.
Affected patients were cohorted and examined only with
gowns, gloves and masks in accordance with the guide-
lines established by the AAP for older children [7]. While
anecdotal, such policies should also be considered in the
NICU population.
Once detection of RSV had occurred in our unit, all infants
cared for by the patient’s nurse for the past 10 days were
tested for RSV infection. RSV infection was detected in
two other infants, including the patient’s brother, who was
symptomatic with rhinorrhea and coughing. The patients
were cohorted and assigned one nurse with strict contact
precautions observed. No specific medical team was
assigned to these three patients and the NICU was not
fumigated. Palivizumab, was administered to all infants
meeting the AAP pre-discharge and outpatient criteria for
preventive administration after surveillance testing docu-
mented the patients as RSV negative. Additional discussion
with families and staff was enforced regarding the
importance to restrict visitation by individuals with
respiratory infections. No further cases were identified.
Conclusions
While there is no controlled study on the use of
palivizumab for the prophylaxis of NICU patients during
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an outbreak of RSV in the NICU, this case adds to
anecdotal evidence such measures should be considered
upon detection of secondary cases of RSV [10]. As
infection control measures are now standard of care for
the prevention of nosocomial RSV and outbreaks in the
NICU tend to consist of a small number of patients, it is
doubtful a controlled study with significant statistical
power will be undertaken soon, making the exact benefit
of palivizumab administration in this setting difficult to
define.
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